Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

saponin-based immunoadjuvant OBI-821

A purified, natural saponin isolated from the soapbark tree Quillaja saponaria Molina with potential immunoadjuvant activity. When co-administered with a vaccine, OBI-821 may increase antibody and cytotoxic T-lymphocyte (CTL) responses against the vaccine's targeted antigen(s).

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	OBI-821 OPT-821

saponin-based immunoadjuvant OBI-821

Search NCI's Drug Dictionary